Login / Signup

Exposure to PM 2.5 and its constituents is associated with metabolic dysfunction-associated fatty liver disease: a cohort study in Northwest of China.

Yamin ZhaoYindi PengMinzhen WangYanan ZhaoYingqian HeLulu ZhangJing LiuShan Zheng
Published in: Environmental geochemistry and health (2024)
Accumulating animal studies have demonstrated associations between ambient air pollution (AP) and metabolic dysfunction-associated fatty liver disease (MAFLD), but relevant epidemiological evidence is limited. We evaluated the association of long-term exposure to AP with the risk of incident MAFLD in Northwest China. The average AP concentration between baseline and follow-up was used to assess individual exposure levels. Cox proportional hazard models and restricted cubic spline functions (RCS) were used to estimate the association of PM 2.5 and its constituents with the risk of MAFLD and the dose-response relationship. Quantile g-computation was used to assess the joint effects of mixed exposure to air pollutants on MAFLD and the weights of the various pollutants. We observed 1516 cases of new-onset MAFLD, with an incidence of 10.89%. Increased exposure to pollutants was significantly associated with increased odds of MAFLD, with hazard ratios (HRs) of 2.93 (95% CI: 1.22, 7.00), 2.86 (1.44, 5.66), 7.55 (3.39, 16.84), 4.83 (1.89, 12.38), 3.35 (1.35, 8.34), 1.89 (1.02, 1.62) for each interquartile range increase in PM 2.5 , SO 4 2- , NO 3 - , NH 4 + , OM, and BC, respectively. Stratified analyses suggested that females, frequent exercisers and never-drinkers were more susceptible to MAFLD associated with ambient PM 2.5 and its constituents. Mixed exposure to SO 4 2- , NO 3 - , NH 4 + , OM and BC was associated with an increased risk of MAFLD, and the weight of BC had the strongest effect on MAFLD. Exposure to ambient PM 2.5 and its constituents increased the risk of MAFLD.
Keyphrases
  • air pollution
  • particulate matter
  • lung function
  • heavy metals
  • polycyclic aromatic hydrocarbons
  • transcription factor
  • risk assessment
  • chronic obstructive pulmonary disease
  • ionic liquid
  • case control